Compare Inovio Pharmaceuticals Inc (INO) vs Packaging Corporation of America (PKG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Inovio Pharmaceuticals Inc vs Packaging Corporation of America — how do they compare? Inovio Pharmaceuticals Inc trades at $1.08 (market cap $89.27M), while Packaging Corporation of America trades at $228.56 (market cap $20.77B). The key difference: Packaging Corporation of America is far larger — about 232.7× Inovio Pharmaceuticals Inc's market cap, and Packaging Corporation of America pays a 2.57% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| INO | PKG | |
|---|---|---|
Market Cap | $89.27M | $20.77B |
Sector | Health | Technology |
52-Week High | $2.87 | $246.31 |
52-Week Low | $1.05 | $191.41 |
Enterprise Value | $60.28M | $24.59B |
Dividend Yield | — | 2.57% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
INO trades at $1.07, down 4.46% today, reflecting persistent bearish technical signals. The company shows minimal revenue of $65.34K (2025) with a net loss of $84.95M, resulting in a negative net margin of 130,000%. Despite beating recent EPS estimates, cash flow remains negative. Key near-term catalyst is the FDA's PDUFA decision on INO-3107 by October 30, 2026.
Outlook hinges on regulatory success for INO-3107; approval could drive significant upside, but failure poses substantial risk. High cash burn and lack of profitability underscore speculative nature. Analyst consensus is cautiously optimistic with 53% buy ratings, yet financial health remains precarious without near-term revenue growth.
Packaging Corporation of America (PKG) trades at $228.43, down 1.99% today, with mixed technical signals showing bullish moving averages but neutral oscillators. The company reported Q1 2026 EPS of $2.40, beating estimates, but faces margin pressure with net income expected to decline to $741 million in 2026. Recent developments include a 20% dividend increase and upcoming Q2 earnings on July 22, 2026.
PKG presents a balanced outlook with strong institutional support and dividend growth offset by earnings volatility and margin compression. The consensus price target of $256.14 suggests 12% upside potential, but investors should monitor Q2 results and cost management amid inflationary pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →About Packaging Corporation of America
Packaging Corporation of America is a leading producer of containerboard and corrugated packaging products in North America. The company also produces white papers, which include printing and writing papers. PKG operates as an integrated manufacturer, with a strong focus on high-quality and sustainable packaging solutions for e-commerce, food and beverage, and other industrial and consumer markets.
Read more on PKG →
